Pancreatic stent in prevention of postoperative acute pancreatitis in patients with benign biliary stricture treated by full-covered self-expanding removable metal stents
10.3760/cma.j.issn.1007-631X.2018.09.004
- VernacularTitle:胰管支架预防全覆膜金属支架治疗良性胆管狭窄术后急性胰腺炎
- Author:
Cheng ZHANG
1
;
Hai HU
;
Hongwei ZHANG
;
Yulong YANG
;
Meiju LIN
;
Gang ZHAO
;
Yuefeng MA
Author Information
1. 同济大学附属东方医院胆石病中心
- Keywords:
Cholangiopancreatography,endoscopic retrograde;
Pancreatitis;
Full-covered self-expanding removable metal stent;
Benign biliary stricture
- From:
Chinese Journal of General Surgery
2018;33(9):725-728
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical value,safety and efficacy of pancreatic stent in prevention of postoperative acute pancreatitis in patients with benign biliary stricture (BBS) treated by fullcovered self-expanding removable metal stents (FCSERMSs).Methods From Jan 2011 to Dec 2017,92 BBS patients who met the inclusion criteria were admitted and divided into pancreatic stent (PS) group and control group.The acute pancreatitis (AP) and hyperamylase (HP) after FCSERMS implantation and removal was observed.Results 55 cases in PS group and 37 cases in control group underwent successful FCSERMS implantation.The incidences of postoperative elevated amylase and HP had no significant differences between the two groups (23.6％ vs.32.4％,3.6％ vs.10.8％,all P ＞0.05).The incidences of postoperative AP and moderately elevated amylase had significant differences (0 vs.13.5％,20.0％ vs.8.1％,all P ＜ 0.05).The average placement time of FCSERMSs was 7.84 ± 1.22 months.The incidence of elevated amylase,AP,HP and moderately elevated amylase after the FCSERMS and PS removed had no statistical differences (3.6％ vs.14.3％,0vs.2.9％,0 vs.2.9％,3.6％vs.8.6％,all P＞0.05).Conclusion The placement of pancreatic stents in the treatment of BBS with FCSERMS is a simple,safe and effective method for the prevention of post-ERCP pancreatitis.
